(1) Haahtela T, Tuomisto LE, Pietinalho A, Klaukka T, Erhola M, Kaila M, et al. A 10 year asthma programme in Finland: major change for the better. Thorax 2006 Aug;61(8):663-670.
(2) Price D, Fletcher M, van der Molen T. Asthma control and management in 8,000 European patients: the REcognise Asthma and LInk to Symptoms and Experience (REALISE) survey. NPJ Prim Care Respir Med 2014 Jun 12;24:14009.
(3) Perret JL, Bonevski B, McDonald CF, Abramson MJ. Smoking cessation strategies for patients with asthma: improving patient outcomes. J Asthma Allergy 2016 Jun 24;9:117-128.
(4) Polosa R, Thomson NC. Smoking and asthma: dangerous liaisons. Eur Respir J 2013 Mar;41(3):716-726.
(5) Chatkin JM, Dullius CR. The management of asthmatic smokers. Asthma Res Pract 2016 Jun 20;2:10-016-0025-7. eCollection 2016.
(6) Pedersen SE, Bateman ED, Bousquet J, Busse WW, Yoxall S, Clark TJ, et al. Determinants of response to fluticasone propionate and salmeterol/fluticasone propionate combination in the Gaining Optimal Asthma controL study. J Allergy Clin Immunol 2007 Nov;120(5):1036-1042.
(7) Polosa R, Russo C, Caponnetto P, Bertino G, Sarva M, Antic T, et al. Greater severity of new onset asthma in allergic subjects who smoke: a 10-year longitudinal study. Respir Res 2011 Jan 24;12:16-9921-12-16.
(8) Kämpe M, Lisspers K, Ställberg B, Sundh J, Montgomery S, Janson C. Determinants of uncontrolled asthma in a Swedish asthma population: cross-sectional observational study. Eur Clin Respir J 2014 Sep 12;1:10.3402/ecrj.v1.24109. eCollection 2014.
(9) Braido F, Brusselle G, Guastalla D, Ingrassia E, Nicolini G, Price D, et al. Determinants and impact of suboptimal asthma control in Europe: The INTERNATIONAL CROSS-SECTIONAL AND LONGITUDINAL ASSESSMENT ON ASTHMA CONTROL (LIAISON) study. Respir Res 2016 May 14;17(1):51-016-0374-z.
(10) Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. 2015; Available at: www.ginasthma.org, 2015.
(11) Kiljander T, Helin T, Venho K, Jaakkola A, Lehtimaki L. Prevalence of asthma-COPD overlap syndrome among primary care asthmatics with a smoking history: a cross-sectional study. NPJ Prim Care Respir Med 2015 Jul 16;25:15047.
(12) Ilmarinen P, Tuomisto LE, Niemela O, Kankaanranta H. Prevalence of Patients Eligible for Anti-IL-5 Treatment in a Cohort of Adult-Onset Asthma. J Allergy Clin Immunol Pract 2019 Jan;7(1):165-174.e4.
(13) Tommola M, Ilmarinen P, Tuomisto LE, Lehtimäki L, Niemela O, Nieminen P, et al. Cumulative effect of smoking on disease burden and multimorbidity in adult-onset asthma. Eur Respir J 2019 Sep 5;54(3):10.1183/13993003.01580-2018. Print 2019 Sep.
(14) Bateman ED, Boushey HA, Bousquet J, Busse WW, Clark TJ, Pauwels RA, et al. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study. Am J Respir Crit Care Med 2004 Oct 15;170(8):836-844.
(15) Chalmers GW, Macleod KJ, Little SA, Thomson LJ, McSharry CP, Thomson NC. Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma. Thorax 2002 Mar;57(3):226-230.
(16) Tomlinson JE, McMahon AD, Chaudhuri R, Thompson JM, Wood SF, Thomson NC. Efficacy of low and high dose inhaled corticosteroid in smokers versus non-smokers with mild asthma. Thorax 2005 Apr;60(4):282-287.